Pay in 4 interest-free payments of $5.16 Learn more
Ships within 48 hours · Estimated delivery Oct 25 - Oct 30
Global GLP-1 Receptor Agonist Market Size, Share, and COVID-19 Impact Analysis, By Drug Class (Semaglutide, Dulaglutide, Liraglutide, Exenatide), By Type (Victoza, Ozempic, Saxenda, Trulicity, Bydureon), By Application (Type 2 Diabetes, Obesity, and Others), By Route of Administration (Parenteral and Oral), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2022 2032 Industry: Healthcare Global GLP-1 Receptor Agonist Market Insights Forecasts to 2032 The Global GLP-1 Receptor Agonist Market Size was valued at USD 13.4 Billion in 2022
:max_bytes(150000):strip_icc():focal(708x512:710x514)/Most-Effective-for-Weight-Loss-051325-03-aa176967f3b940f083cbad0ad3d12d4d.jpg)
To account for multiple hypothesis testing across dermatologic outcomes, P values were adjusted using the BenjaminiHochberg false discovery rate procedure ( Results Baseline characteristics Before propensity score matching, substantial differences were observed between patients initiating GLP-1 RAs and those initiating DPP-4is ( Table 1 )
This unique design allows for the medication to be absorbed through the oral mucosa, leading to targeted local or systemic effects
March 20, 2024
doi: 10.3390/ijms21218290 162
US$ 24.59
US$ 26.52
US$ 20.95
US$ 28.89
US$ 26.82
